| Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock B Zheng, U Albrecht, K Kaasik, M Sage, W Lu, S Vaishnav, Q Li, ZS Sun, ... Cell 105 (5), 683-694, 2001 | 1094 | 2001 |
| Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. X Wu, M Wakamiya, S Vaishnav, R Geske, C Montgomery Jr, P Jones, ... Proceedings of the National Academy of Sciences 91 (2), 742-746, 1994 | 410 | 1994 |
| Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice. M Wakamiya, MR Blackburn, R Jurecic, MJ McArthur, RS Geske, ... Proceedings of the National Academy of Sciences 92 (9), 3673-3677, 1995 | 184 | 1995 |
| Instability of the Expanded (CTG) nRepeats in the Myotonin Protein Kinase Gene in Cultured Lymphoblastoid Cell Lines from Patients with Myotonic Dystrophy T Ashizawa, DG Monckton, S Vaishnav, BJ Patel, A Voskova, CT Caskey Genomics 36 (1), 47-53, 1996 | 49 | 1996 |
| Construction of a defective retrovirus containing the human hypoxanthine phosphoribosyltransferase cDNA and its expression in cultured cells and mouse bone marrow SMW Chang, K Wager-Smith, TY Tsao, J Henkel-Tigges, S Vaishnav, ... Molecular and cellular biology 7 (2), 854-863, 1987 | 40 | 1987 |
| Bigenic Cre/loxP, puΔtk conditional genetic ablation YT Chen, R Levasseur, S Vaishnav, G Karsenty, A Bradley Nucleic acids research 32 (20), e161-e161, 2004 | 22 | 2004 |
| A two-component conditional genetic ablation system using puDtk and the Cre/loxP technology R Levasseur, Y Chen, S Vaishnav, G Karsenty, RR Behringer, A Bradley CALCIFIED TISSUE INTERNATIONAL 74, S128-S128, 2004 | 1 | 2004 |
| Hyperurikämie und Gichtosteoarthropathie (Arthropathia urica) GL Bach, H Müller-Faßbender, KP Stock, KK Förster Arthritis und Rheuma 26 (01), 27-44, 2006 | | 2006 |
| A TWO-COMPONENT CONDITIONAL GENETIC ABLATION SYSTEM USING PU Delta TK AND THE Cre/LoxP TECHNOLOGY YT Chen, R Levasseur, S Vaishnav, G Karsenty, RR Behringer, A Bradley RHEUMATOLOGY 42, 124-124, 2003 | | 2003 |
